Editing the Genome of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes
- 26 March 2019
- book chapter
- Published by Springer Nature
- Vol. 1961, 153-183
Abstract
Genome editing using the CRISPR/Cas9 system has rapidly established itself as an essential tool in the genetic manipulation of many organisms, including human cell lines. Its application to human induced pluripotent stem cells (hiPSCs) allows for the generation of isogenic cell pairs that differ in a single genetic lesion, and therefore the identification and characterization of causal genetic variants. We describe a simple, effective approach to perform delicate manipulations of the genome of hiPSCs through delivery of Cas9 RNPs along with ssDNA oligonucleotide repair templates that can generate mutations in up to 98% of single cell clones and introduce single nucleotide changes at an efficiency of up to 40%. We describe our use of a T7 endonuclease assay to identify active guide RNAs, and a high-throughput sequencing genotyping strategy that allows the identification of correctly edited clones. We also present our experiences of generating single nucleotide changes at 15 sites, which show considerable variability between both guides and target sites in the efficiency at which such changes can be introduced.Keywords
This publication has 28 references indexed in Scilit:
- CRISPR–Cas9 genome editing in human cells occurs via the Fanconi anemia pathwayNature Genetics, 2018
- Mechanisms of precise genome editing using oligonucleotide donorsGenome Research, 2017
- Editing the genome of hiPSC with CRISPR/Cas9: disease modelsMammalian Genome, 2017
- Two Distinct Pathways Support Gene Correction by Single-Stranded Donors at DNA NicksCell Reports, 2016
- Rapid and highly efficient mammalian cell engineering via Cas9 protein transfectionJournal of Biotechnology, 2015
- Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteinsGenome Research, 2014
- DNA targeting specificity of RNA-guided Cas9 nucleasesNature Biotechnology, 2013
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- Regulation of DNA double-strand break repair pathway choiceCell Research, 2007
- Enhancing Gene Targeting with Designed Zinc Finger NucleasesScience, 2003